Detalhe da pesquisa
1.
Blinded Withdrawal of Long-Term Randomized Treatment With Empagliflozin or Placebo in Patients With Heart Failure.
Circulation
; 148(13): 1011-1022, 2023 09 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37621153
2.
Empagliflozin in Heart Failure with a Preserved Ejection Fraction.
N Engl J Med
; 385(16): 1451-1461, 2021 10 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34449189
3.
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure.
N Engl J Med
; 383(15): 1413-1424, 2020 10 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32865377
4.
Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction.
Eur Heart J
; 43(5): 416-426, 2022 Feb 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34878502
5.
Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function: Insights From EMPEROR-Reduced.
Circulation
; 143(4): 310-321, 2021 01 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-33095032
6.
Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved Trial.
Circulation
; 144(16): 1284-1294, 2021 10 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34459213
7.
Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection Fraction: The EMPEROR-Reduced Trial.
Circulation
; 143(4): 326-336, 2021 01 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-33081531
8.
Empagliflozin and health-related quality of life outcomes in patients with heart failure with reduced ejection fraction: the EMPEROR-Reduced trial.
Eur Heart J
; 42(13): 1203-1212, 2021 03 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-33420498
9.
Effect of empagliflozin on exercise ability and symptoms in heart failure patients with reduced and preserved ejection fraction, with and without type 2 diabetes.
Eur Heart J
; 42(6): 700-710, 2021 02 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33351892
10.
Empagliflozin and Major Renal Outcomes in Heart Failure.
N Engl J Med
; 385(16): 1531-1533, 2021 10 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34449179
11.
Empagliflozin Is Associated With a Lower Risk of Post-Acute Heart Failure Rehospitalization and Mortality.
Circulation
; 139(11): 1458-1460, 2019 03 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30855996
12.
Rationale, design and baseline characteristics of a 4-year (208-week) phase III trial of empagliflozin, an SGLT2 inhibitor, versus glimepiride as add-on to metformin in patients with type 2 diabetes mellitus with insufficient glycemic control.
Cardiovasc Diabetol
; 12: 129, 2013 Sep 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-24007456
13.
Recurrent Events in Cardiovascular Trials: JACC State-of-the-Art Review.
J Am Coll Cardiol
; 82(14): 1445-1463, 2023 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37758440
14.
Recency of Heart Failure Hospitalization, Outcomes, and the Effect of Empagliflozin: An EMPEROR-Pooled Analysis.
JACC Heart Fail
; 11(6): 702-712, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36872213
15.
Impact of Empagliflozin in Heart Failure With Reduced Ejection Fraction in Patients With Ischemic Versus Nonischemic Cause.
J Am Heart Assoc
; 12(1): e027652, 2023 01 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36565199
16.
The win ratio method in heart failure trials: lessons learnt from EMPULSE.
Eur J Heart Fail
; 25(5): 632-641, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37038330
17.
Impact of anaemia and the effect of empagliflozin in heart failure with reduced ejection fraction: findings from EMPEROR-Reduced.
Eur J Heart Fail
; 24(4): 708-715, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34957660
18.
Mineralocorticoid Receptor Antagonists and Empagliflozin in Patients With Heart Failure and Preserved Ejection Fraction.
J Am Coll Cardiol
; 79(12): 1129-1137, 2022 03 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35331406
19.
Minimally Clinically Important Difference in Health Status Scores in Patients With HFrEF vs HFpEF.
JACC Heart Fail
; 10(9): 651-661, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35780032
20.
Outcomes with empagliflozin in heart failure with preserved ejection fraction using DELIVER-like endpoint definitions.
Eur J Heart Fail
; 24(8): 1400-1405, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35604680